Implications of inflammatory cell death-PANoptosis in health and disease
- 10 July 2024
- journal article
- review article
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 47 (7) , 617-631
Abstract
Regulated cell death (RCD) pathways, such as pyroptosis, apoptosis, and necroptosis, are essential for maintaining the body’s balance, defending against pathogens, and eliminating abnormal cells that could lead to diseases like cancer. Although these pathways operate through distinct mechanisms, recent genetic and pharmacological studies have shown that they can interact and influence each other. The concept of “PANoptosis” has emerged, highlighting the interplay between pyroptosis, apoptosis, and necroptosis, especially during cellular responses to infections. This article provides a concise overview of PANoptosis and its molecular mechanisms, exploring its implications in various diseases. The review focuses on the extensive interactions among different RCD pathways, emphasizing the role of PANoptosis in infections, cytokine storms, inflammatory diseases, and cancer. Understanding PANoptosis is crucial for developing novel treatments for conditions involving infections, sterile inflammations, and cancer.Keywords
Funding Information
- new faculty startup funds from Seoul National University (2023-0024)
- National Research Foundation of Korea (RS-2023-00251395)
- Woosuk University
- National Research Foundation of Korea (RS-2024-00355169)
This publication has 91 references indexed in Scilit:
- Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunitiesArchives of Pharmacal Research, 2023
- Tumor lactic acid: a potential target for cancer therapyArchives of Pharmacal Research, 2023
- Innate immune sensing of pathogens and its post-transcriptional regulations by RNA-binding proteinsArchives of Pharmacal Research, 2023
- The role and application of transcriptional repressors in cancer treatmentArchives of Pharmacal Research, 2023
- Single cell analysis of PANoptosome cell death complexes through an expansion microscopy methodCellular and Molecular Life Sciences, 2022
- Function and therapeutic development of exosomes for cancer therapyArchives of Pharmacal Research, 2022
- CD48-expressing non-small-cell lung cancer cells are susceptible to natural killer cell–mediated cytotoxicityArchives of Pharmacal Research, 2021
- ACY-241, an HDAC6 inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by inducing autophagyArchives of Pharmacal Research, 2021
- Kaempferol sensitizes cell proliferation inhibition in oxaliplatin-resistant colon cancer cellsArchives of Pharmacal Research, 2021
- Hallmarks of Cancer: The Next GenerationCell, 2011